Manerix

moclobemide

A reversible mono-amine oxidase inhibitor (MAOI) used to manage depression and performance anxiety. It is not approved for use in the USA.
 
Adverse effects
Insomnia, headache, dizziness.

Manerix®

Moclobemide, see there.
References in periodicals archive ?
The product rights to Flupirtine, Onsolis and Sublinox are returned to Meda, and Valeant will continue to run the business in Canada, including the products Palafer, Contac, and Manerix.